Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

J&J to Initially Spend $1.5B for Elan’s Alzheimer’s Immunotherapy Program

J&J is buying a $1 billion stake in Elan and creating a new firm seeded with $500 million to continue R&D.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »